inc Event Ads
Recent News
- Pridopidine for ALS – promising results
- Managing drug resistant epilepsy (DRE)
- Data challenges migraine treatment pauses
- Kisunla (donanemab) gains full FDA approval
- CE Mark for Image Guided Programming Software for Deep Brain Stimulation
- King’s Parkinson’s Charitable Fund launches
- How can scientists model the human brain?
- WFNR Franz Gerstenbrand Award 2024 Winner
- Urgent findings from head-CT scans prioritised by AI at NHS Greater Glasgow and Clyde
- Trofinetide for Rett Syndrome – new drug submission in Canada
Categories
- ACNR News (8)
- Acquired Brain Injury (12)
- Alzheimer's Disease (14)
- Amyotrophic Lateral Sclerosis (ALS) (6)
- Artificial Intelligence (4)
- Association of British Neurologists Trainees (4)
- Australia/New Zealand (1)
- Awards & Appointments (6)
- Book Reviews (2)
- Brain Mapping (1)
- Brain tumours (2)
- Case Reports (15)
- Charcot-Marie-Tooth Disease (1)
- Charity (5)
- Cognition (1)
- Comment (2)
- Course & Conference Previews (11)
- Courses & Conferences (1)
- COVID-19 Articles (3)
- Dementia (1)
- Epilepsy (13)
- Essay (1)
- Headache (14)
- Hereditary Spastic Paraplegia (1)
- Huntington's disease (2)
- Industry News (177)
- Journal Reviews (1)
- Major Depressive Disorder (3)
- Management Topics in Epilepsy (1)
- Multiple Sclerosis (23)
- Myasthenia Gravis (6)
- Neurodevelopmental disorders (1)
- Neuroimmunology (2)
- Neurological Literature (2)
- Neurology News (37)
- Neuropsychiatry (2)
- Neurosurgery (1)
- NHS News (2)
- Online First (14)
- Pain (3)
- Parkinson’s Disease (16)
- Rehabilitation (10)
- Rehabilitation Articles (4)
- Research (2)
- Sleep (1)
- Sleep Series (4)
- Special Feature (6)
- Sponsored Feature (7)
- Stroke (8)
- Stroke Series (3)
- Syncope (1)
- Uncategorised (43)
- Uncategorized (1)
